Tango Therapeutics Inc (NASDAQ: TNGX) kicked off on Monday, down -7.35% from the previous trading day, before settling in for the closing price of $8.30. Over the past 52 weeks, TNGX has traded in a range of $5.15-$13.03.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 132.62%. While this was happening, its average annual earnings per share was recorded -22.90%. With a float of $57.71 million, this company’s outstanding shares have now reached $102.20 million.
Let’s determine the extent of company efficiency that accounts for 140 employees.
Tango Therapeutics Inc (TNGX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Tango Therapeutics Inc is 46.14%, while institutional ownership is 56.74%. The most recent insider transaction that took place on Sep 13 ’24, was worth 709,756. In this transaction 10% Owner of this company sold 67,400 shares at a rate of $10.53, taking the stock ownership to the 16,859,075 shares. Before that another transaction happened on Sep 13 ’24, when Company’s Affiliate proposed sale 67,400 for $10.50, making the entire transaction worth $707,700.
Tango Therapeutics Inc (TNGX) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.23 earnings per share (EPS), higher than consensus estimate (set at -0.34) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -22.90% per share during the next fiscal year.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Take a look at Tango Therapeutics Inc’s (TNGX) current performance indicators. Last quarter, stock had a quick ratio of 7.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Looking closely at Tango Therapeutics Inc (NASDAQ: TNGX), its last 5-days average volume was 1.49 million, which is a jump from its year-to-date volume of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 8.01%. Additionally, its Average True Range was 0.91.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 22.14%, which indicates a significant increase from 0.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 108.40% in the past 14 days, which was higher than the 75.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.84, while its 200-day Moving Average is $9.41. However, in the short run, Tango Therapeutics Inc’s stock first resistance to watch stands at $8.18. Second resistance stands at $8.68. The third major resistance level sits at $8.94. If the price goes on to break the first support level at $7.42, it is likely to go to the next support level at $7.16. Should the price break the second support level, the third support level stands at $6.66.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
The company with the Market Capitalisation of 823.91 million has total of 106,846K Shares Outstanding. Its annual sales at the moment are 36,530 K in contrast with the sum of -101,740 K annual income. Company’s last quarter sales were recorded 19,880 K and last quarter income was -25,550 K.
